EBM Technologies Incorporated (TPEX:8409)
19.35
+0.15 (0.78%)
Jun 4, 2026, 1:30 PM CST
EBM Technologies Revenue
EBM Technologies had revenue of 51.64M TWD in the quarter ending March 31, 2026, with 121.82% growth. This brings the company's revenue in the last twelve months to 281.47M, up 1.49% year-over-year. In the year 2025, EBM Technologies had annual revenue of 253.11M, down -9.91%.
Revenue (ttm)
281.47M
Revenue Growth
+1.49%
P/S Ratio
2.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
614.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.11M | -27.85M | -9.91% |
| Dec 31, 2024 | 280.95M | 74.81M | 36.29% |
| Dec 31, 2023 | 206.15M | -177.74M | -46.30% |
| Dec 31, 2022 | 383.88M | 188.95M | 96.93% |
| Dec 31, 2021 | 194.93M | -20.40M | -9.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 24.42B |
| PharmaEssentia | 17.50B |
| Bioray Biotech | 222.73M |
| Vectorite Biomedical | 61.41M |
| Caliway Biopharmaceuticals | 38.04M |
| SynCore Biotechnology Co.,Ltd | 27.78M |
| Heron Neutron Medical | 12.96M |